KADCYLA

NDC 50242-088 · Genentech, Inc.

Generic nameADO-TRASTUZUMAB EMTANSINE

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)TRASTUZUMAB EMTANSINE

Strength20 mg/mL

Marketing categoryBLA

Packages

50242-088-01 — 1 VIAL, SINGLE-USE in 1 CARTON (50242-088-01) / 5 mL in 1 VIAL, SINGLE-USE

J9354 — Injection, ado-trastuzumab emtansine, 1 mg Medicare Part B payment limit (ASP + 6%): $43.63

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.